Science
SARS-CoV-2 triggers antibodies from previous coronavirus infections – Drug Target Review
A new study has shown that previous coronavirus infection may contribute to the immune response of patients infected with SARS-CoV-2.
Posted: 22 January 2021 | Victoria Rees (Drug Target Review) | No comments yet
A new study has shown that previous coronavirus infection may contribute to the immune response of patients infected with SARS-CoV-2.
The results of a new study have suggested that the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease.
The study was conducted at Northern Arizona University and the Translational Genomics…
-
General13 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News22 hours agoBetty’s Burgers National Burger Day
-
General24 hours agoThree maps that show the scale of the NSW flood disaster
-
General14 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire